TY - JOUR
T1 - Impact of preparatory coronary protection in patients at high anatomical risk of acute coronary obstruction during transcatheter aortic valve implantation
AU - Yamamoto, Masanori
AU - Shimura, Tetsuro
AU - Kano, Seiji
AU - Kagase, Ai
AU - Kodama, Atsuko
AU - Koyama, Yutaka
AU - Watanabe, Yusuke
AU - Tada, Norio
AU - Takagi, Kensuke
AU - Araki, Motoharu
AU - Shirai, Shinichi
AU - Hayashida, Kentaro
N1 - Publisher Copyright:
© 2016 Published by Elsevier Ireland Ltd.
PY - 2016/8/15
Y1 - 2016/8/15
N2 - Background This study aimed to assess the effectiveness of preparatory coronary protection (CP) in patients considered at high risk of acute coronary obstruction (ACO) after transcatheter aortic valve implantation (TAVI). Methods The Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) Japanese multicenter registry enrolled 666 consecutive patients. All patients were assessed by preprocedural multidetector computed tomography. CP using a guide wire with or without a balloon was prospectively performed according to the following criteria: 1) coronary height length from the annulus < 10 mm, 2) evidence of ACO during balloon aortic valvuloplasty with simultaneous aortic injection, and 3) shallow valsalva or bulky calcification on the leaflet. The incidence of ACO and other procedural outcomes were compared between the CP and non-CP groups. Results CP was performed in 14.1% of all patients (94/666). ACO had an incidence of 1.5% (10/666) and mainly occurred in women (70%) and the left coronary artery (70%). The ACO rate was significantly higher in the CP group than in the non-CP group (7.4% [7/94] vs. 0.5% [3/572]; p < 0.001), although notably 30% of ACO were occurred in non-CP group. All 10 ACO cases were successfully treated by catheter intervention, although periprocedural myocardial injury occurred in 42.9% of patients with CP group and 33.3% of those without CP group. Mortality and other periprocedural complications did not significantly differ between the 2 groups. Conclusion The preparatory CP strategy was feasible for the management of ACO during TAVI, but the complication of ACO was difficult to predict completely.
AB - Background This study aimed to assess the effectiveness of preparatory coronary protection (CP) in patients considered at high risk of acute coronary obstruction (ACO) after transcatheter aortic valve implantation (TAVI). Methods The Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) Japanese multicenter registry enrolled 666 consecutive patients. All patients were assessed by preprocedural multidetector computed tomography. CP using a guide wire with or without a balloon was prospectively performed according to the following criteria: 1) coronary height length from the annulus < 10 mm, 2) evidence of ACO during balloon aortic valvuloplasty with simultaneous aortic injection, and 3) shallow valsalva or bulky calcification on the leaflet. The incidence of ACO and other procedural outcomes were compared between the CP and non-CP groups. Results CP was performed in 14.1% of all patients (94/666). ACO had an incidence of 1.5% (10/666) and mainly occurred in women (70%) and the left coronary artery (70%). The ACO rate was significantly higher in the CP group than in the non-CP group (7.4% [7/94] vs. 0.5% [3/572]; p < 0.001), although notably 30% of ACO were occurred in non-CP group. All 10 ACO cases were successfully treated by catheter intervention, although periprocedural myocardial injury occurred in 42.9% of patients with CP group and 33.3% of those without CP group. Mortality and other periprocedural complications did not significantly differ between the 2 groups. Conclusion The preparatory CP strategy was feasible for the management of ACO during TAVI, but the complication of ACO was difficult to predict completely.
KW - Acute coronary obstruction
KW - Coronary protection
KW - Transcatheter aortic valve implantation
UR - http://www.scopus.com/inward/record.url?scp=84966291996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84966291996&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2016.04.185
DO - 10.1016/j.ijcard.2016.04.185
M3 - Article
C2 - 27179209
AN - SCOPUS:84966291996
SN - 0167-5273
VL - 217
SP - 58
EP - 63
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -